Prestige Consumer Healthcare (PBH) Fails to deliver data

Key failure to deliver metrics for Prestige Consumer Healthcare:

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: €2.36 M
• Last 12 months FTD volume: €6.09 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Prestige Consumer Healthcare (PBH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Prestige Consumer Healthcare (PBH) - since 2013

Prestige Consumer Healthcare (PBH) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	€72.01 M	€0.40 B	🇬🇧 UK
Pfizer PFE	€24.63 M	€0.10 B	🇺🇸 USA
Rite Aid RAD	€12.18 M	€30.91 M	🇺🇸 USA
Johnson & Johnson JNJ	€54.31 M	€94.31 M	🇺🇸 USA
Taro Pharmaceutical TARO	N/A	€0.62 M	🇮🇱 Israel
Novartis NVS	€18.77 M	€0.12 B	🇨🇭 Switzerland
Procter & Gamble PG	€33.65 M	€0.34 B	🇺🇸 USA
CVS Health CVS	€31.05 M	€0.18 B	🇺🇸 USA
Clorox CLX	€12.18 M	€0.11 B	🇺🇸 USA
Abbott Laboratories ABT	€72.42 M	€0.44 B	🇺🇸 USA